Clinical Trials Directory

Trials / Conditions / Non-melanomatous Skin Cancer

Non-melanomatous Skin Cancer

28 registered clinical trials studyying Non-melanomatous Skin Cancer.

StatusTrialSponsorPhase
TerminatedTopical Aminolevulinic Acid in Patients With Nonmelanoma Skin Cancer
NCT00663910
The Cleveland ClinicEARLY_Phase 1
UnknownPhotodynamic Therapy Using Aminolevulinic Acid in Treating Patients With Skin Cancer
NCT00747903
Laser and Skin Surgery Center of New YorkPhase 2
TerminatedStudying a Tumor Marker for Testicular Cancer, Skin Cancer, Small Intestine Cancer, and Pancreatic Cancer
NCT00899132
Case Comprehensive Cancer Center
UnknownBioelectric Field Imaging in Diagnosing Melanoma and Other Skin Cancers in Patients With Skin Lesions
NCT00391300
Eastern Virginia Medical SchoolPhase 1
UnknownGefitinib and PEG-Interferon Alfa-2a in Treating Patients With Unresectable or Metastatic Skin Cancer
NCT00423397
University of California, San DiegoPhase 1 / Phase 2
CompletedLMB-2 Immunotoxin and Vaccine Therapy in Treating Patients With Metastatic Melanoma That Cannot Be Removed By
NCT00295958
National Institutes of Health Clinical Center (CC)Phase 2
CompletedPhotodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disea
NCT00103246
Case Comprehensive Cancer CenterPhase 1
UnknownComputer-Based Continuing Education for Doctors in Examination and Counseling of Patients on Skin Cancer or We
NCT00295906
Rhode Island HospitalN/A
CompletedEffect of Solar-Simulated Ultraviolet Radiation on Gene Expression in Unprotected and Sunscreen-Protected Skin
NCT00099112
National Cancer Institute (NCI)
CompletedImiquimod Cream in Treating Patients With Basal Cell Skin Cancer
NCT00079300
National Naval Medical CenterPhase 1
CompletedAcitretin in Preventing Skin Cancer in Patients at High Risk for Skin Cancer
NCT00644384
Mayo ClinicN/A
CompletedTopical Imiquimod Compared With Surgery in Treating Patients With Basal Cell Skin Cancer
NCT00066872
Queen's Medical CenterPhase 3
TerminatedPhotodynamic Therapy in Treating Patients With Skin Cancer or Solid Tumors Metastatic to the Skin
NCT00023790
Case Comprehensive Cancer CenterPhase 1
CompletedEflornithine With or Without Triamcinolone in Preventing Nonmelanoma Skin Cancer in Patients With Actinic Kera
NCT00021294
University of ArizonaPhase 2
CompletedCelecoxib in Preventing Basal Cell Carcinoma in Patients With Basal Cell Nevus Syndrome
NCT00023621
University of California, San FranciscoPhase 2
CompletedSU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck
NCT00006361
Memorial Sloan Kettering Cancer CenterPhase 2
CompletedRadiation Therapy in Treating Patients With Head and Neck Cancer
NCT00021125
Medical Research CouncilPhase 3
CompletedAcitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ
NCT00003611
Alliance for Clinical Trials in OncologyN/A
CompletedPhotodynamic Therapy in Treating Patients With Basal Cell Skin Cancer
NCT00017485
Roswell Park Cancer InstitutePhase 1
TerminatedGreen Tea Extract in Treating Patients With Actinic Keratosis
NCT00005097
Frank MeyskensPhase 2
CompletedPhotodynamic Therapy in Treating Patients With Skin Cancer
NCT00002975
Roswell Park Cancer InstitutePhase 2
CompletedPhotodynamic Therapy in Treating Patients With Skin Cancer
NCT00002963
Roswell Park Cancer InstitutePhase 2
CompletedIsotretinoin Plus Interferon in Treating Patients With Recurrent Cancer
NCT00002506
Hoag Memorial Hospital PresbyterianPhase 2
CompletedIsotretinoin in Preventing Skin Cancer
NCT00025012
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)N/A
UnknownLow Fat Diet to Prevent Disease Progression in Patients With Skin Cancer
NCT00003097
Baylor College of MedicinePhase 2
CompletedEflornithine to Prevent Skin Cancer in Patients With Previously Treated Early Stage Skin Cancer
NCT00005884
University of Wisconsin, MadisonPhase 3
CompletedTopical Sirolimus in Patients With Basal Cell Nevus Syndrome and in Healthy Participants
NCT00433485
Yale UniversityPhase 1
WithdrawnCelecoxib in Preventing Skin Cancer
NCT00025051
National Cancer Institute (NCI)Phase 2